Use of patient-derived stem cells will enable high-throughput drug screening for potential therapeutics — ScienceDaily
The model’s development is described in the January issue of the journal Stem Cell Reports. NEI is part of the National Institutes of Health. “This ‘disease-in-a-dish’ system will help us…
